Viewing Study NCT00323518


Ignite Creation Date: 2025-12-25 @ 4:42 AM
Ignite Modification Date: 2025-12-26 @ 3:43 AM
Study NCT ID: NCT00323518
Status: COMPLETED
Last Update Posted: 2016-04-13
First Post: 2006-05-08
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Phase II Controlled Trial of Velafermin for Prevention of Oral Mucositis
Sponsor: CuraGen Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module